Central Serous Chorioretinopathy

Jay Chhablani is a Professor of Ophthalmology and a Vitreo-Retinal Surgeon at the Department of Ophthalmology at the University of Pittsburgh, Pittsburgh, USA. He is the Director of Clinical Research at the UPMC Vision Institute. He established the “Choroid Analysis and Research (CAR) Lab” at the University of Pittsburgh which focuses on computational as well as biological research in the field of choroid. His areas of interest are macular disorders, automated retinal image analysis and advanced imaging techniques. He has been consistently funded by the National Institute of Health (NIH) and various foundations. He has published more than 550 articles in peer-reviewed journals with a focus in the field of choroid. He is the editor of books “Choroidal Disorders”, “Central Serous Chorioretinopathy” and “Choroidal Neovascularization”. He is on the reviewing boards of all high-impact journals including Science Translational Medicine and Lancet. He is also on the editorial board of several journals including the American Journal of Ophthalmology. He serves on the `grant reviewing board of various funding agencies. He is a member of many esteemed societies such as the Macula Society and Gonin Club. He is a member of various scientific committees in various national and international societies including the American Academy of Ophthalmology. He has delivered more than 200 invited lectures and has been invited for visiting professorship by many universities around the world. He has won several national and international awards and delivered multiple named lectures.

• Section I. Basics1. Pathophysiology of CSCR2. Pachychoroid disease3. Visual Dysfunction in Central Serous Chorioretinopathy4. CSCR classification and its fallacies5. Risk factors6. Genetics Section II. Imaging7. Fundus autofluorescence8. Fundus fluorescein angiography9. Indocyanine green angiography10. Optical coherence tomography 11. Optical coherence tomography angiography 12. Adaptive Optics Imaging in Central Serous Chorioretinopathy13. Other imaging modalities in CSC14. CSCR masquerades15. Bullous variant and other atypical CSCR16. Choroidal neovascularization associated with CSCR Section III. Management17. Conventional laser treatment in CSC18. Subthreshold laser in CSCR 19. Photodynamic therapy in central serous chorioretinopathy20. Oral Agents in the Treatment of Central Serous Chorioretinopathy21. Other therapies in CSCR22. Future research strategies in CSCR23. Retro-Mode Imaging in Central Serous Chorioretinopathy